Literature DB >> 21969016

Wnt signaling mediates pathological vascular growth in proliferative retinopathy.

Jing Chen1, Andreas Stahl, Nathan M Krah, Molly R Seaward, Roberta J Dennison, Przemyslaw Sapieha, Jing Hua, Colman J Hatton, Aimee M Juan, Christopher M Aderman, Keirnan L Willett, Karen I Guerin, Akiko Mammoto, Matthew Campbell, Lois E H Smith.   

Abstract

BACKGROUND: Ischemic proliferative retinopathy, characterized by pathological retinal neovascularization, is a major cause of blindness in working-age adults and children. Defining the molecular pathways distinguishing pathological neovascularization from normal vessels is critical to controlling these blinding diseases with targeted therapy. Because mutations in Wnt signaling cause defective retinal vasculature in humans with some characteristics of the pathological vessels in retinopathy, we investigated the potential role of Wnt signaling in pathological retinal vascular growth in proliferative retinopathy. METHODS AND
RESULTS: In this study, we show that Wnt receptors (Frizzled4 and low-density lipoprotein receptor-related protein5 [Lrp5]) and activity are significantly increased in pathological neovascularization in a mouse model of oxygen-induced proliferative retinopathy. Loss of Wnt coreceptor Lrp5 and downstream signaling molecule dishevelled2 significantly decreases the formation of pathological retinal neovascularization in retinopathy. Loss of Lrp5 also affects retinal angiogenesis during development and formation of the blood-retinal barrier, which is linked to significant downregulation of tight junction protein claudin5 in Lrp5(-/-) vessels. Blocking claudin5 significantly suppresses Wnt pathway-driven endothelial cell sprouting in vitro and developmental and pathological vascular growth in retinopathy in vivo.
CONCLUSIONS: These results demonstrate an important role of Wnt signaling in pathological vascular development in retinopathy and show a novel function of Cln5 in promoting angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969016      PMCID: PMC3326389          DOI: 10.1161/CIRCULATIONAHA.111.040337

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  63 in total

1.  Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.

Authors:  Joanne L Dickinson; Michèle M Sale; Abraham Passmore; Liesel M FitzGerald; Catherine M Wheatley; Kathryn P Burdon; Jamie E Craig; Supaporn Tengtrisorn; Susan M Carden; Hector Maclean; David A Mackey
Journal:  Clin Exp Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 4.207

Review 2.  Wnt/beta-catenin signaling in development and disease.

Authors:  Hans Clevers
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

3.  Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.

Authors:  Mats Hellström; Li-Kun Phng; Jennifer J Hofmann; Elisabet Wallgard; Leigh Coultas; Per Lindblom; Jackelyn Alva; Ann-Katrin Nilsson; Linda Karlsson; Nicholas Gaiano; Keejung Yoon; Janet Rossant; M Luisa Iruela-Arispe; Mattias Kalén; Holger Gerhardt; Christer Betsholtz
Journal:  Nature       Date:  2007-01-28       Impact factor: 49.962

Review 4.  Mining the Wnt pathway for cancer therapeutics.

Authors:  Nick Barker; Hans Clevers
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

5.  Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6.

Authors:  Jonathan L Haines; Nathalie Schnetz-Boutaud; Silke Schmidt; William K Scott; Anita Agarwal; Eric A Postel; Lana Olson; Shannon J Kenealy; Michael Hauser; John R Gilbert; Margaret A Pericak-Vance
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

Review 6.  VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation.

Authors:  Dietmar Vestweber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-27       Impact factor: 8.311

7.  Erythropoietin deficiency decreases vascular stability in mice.

Authors:  Jing Chen; Kip M Connor; Christopher M Aderman; Lois E H Smith
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function.

Authors:  Ruud D Fontijn; Oscar L Volger; Joost O Fledderus; Arie Reijerkerk; Helga E de Vries; Anton J G Horrevoets
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-07       Impact factor: 4.733

9.  A model for familial exudative vitreoretinopathy caused by LPR5 mutations.

Authors:  Chun-Hong Xia; Haiquan Liu; Debra Cheung; Meng Wang; Catherine Cheng; Xin Du; Bo Chang; Bruce Beutler; Xiaohua Gong
Journal:  Hum Mol Genet       Date:  2008-02-09       Impact factor: 6.150

10.  Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models.

Authors:  Eveline H Shue; Eleanor B Carson-Walter; Yang Liu; Bethany N Winans; Zarina S Ali; Jun Chen; Kevin A Walter
Journal:  BMC Neurosci       Date:  2008-02-26       Impact factor: 3.288

View more
  62 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  Oxidative stress upregulates Wnt signaling in human retinal microvascular endothelial cells through activation of disheveled.

Authors:  Chi Zhang; Elizabeth Tannous; Jie J Zheng
Journal:  J Cell Biochem       Date:  2019-04-08       Impact factor: 4.429

3.  Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina.

Authors:  Julia V Busik; Maria B Grant
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-05       Impact factor: 8.311

Review 4.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

Review 5.  The blood-brain barrier.

Authors:  Richard Daneman; Alexandre Prat
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-05       Impact factor: 10.005

6.  Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species.

Authors:  Ajit Vikram; Young-Rae Kim; Santosh Kumar; Asma Naqvi; Timothy A Hoffman; Ajay Kumar; Francis J Miller; Cuk-Seong Kim; Kaikobad Irani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-21       Impact factor: 8.311

Review 7.  Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

Authors:  Elizabeth P Moran; Zhongxiao Wang; Jing Chen; Przemyslaw Sapieha; Lois E H Smith; Jian-Xing Ma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-29       Impact factor: 4.733

8.  The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.

Authors:  Richard L Sidman; Jianxue Li; Matthew Lawrence; Wenzheng Hu; Gary F Musso; Ricardo J Giordano; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap
Journal:  Sci Transl Med       Date:  2015-10-14       Impact factor: 17.956

9.  Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Ye Sun; Yan Gong; Tara L Favazza; Peyton C Morss; Nicholas J Saba; Thomas W Fredrick; Xi He; James D Akula; Jing Chen
Journal:  Am J Pathol       Date:  2016-08-12       Impact factor: 4.307

10.  Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche.

Authors:  Zhiping Liu; Jiean Xu; Qian Ma; Xiaoyu Zhang; Qiuhua Yang; Lina Wang; Yapeng Cao; Zhimin Xu; Amany Tawfik; Ye Sun; Neal L Weintraub; David J Fulton; Mei Hong; Zheng Dong; Lois E H Smith; Ruth B Caldwell; Akrit Sodhi; Yuqing Huo
Journal:  Sci Transl Med       Date:  2020-08-05       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.